Brief: Theraclion to present data from the U.S. pilot trial of echotherapy with Echopulse

Theraclion SA

20/11/2017 07:07

Nov 20 (Reuters) - THERACLION SA  ALTHER.PA  
    * ANNOUNCES THE PRESENTATION OF DATA FROM THE U.S. PILOT 
TRIAL OF 
ECHOTHERAPY WITH ECHOPULSE 
    * RESULTS SUGGEST POSITIVE OUTCOME OF ONGOING PIVOTAL TRIAL 
OF 
ECHOPULSE FOR NON-INVASIVE TREATMENT OF BREAST FIBROADENOMAS 
    * OVER 25% OF PATIENTS HAVE ALREADY BEEN TREATED IN THIS 
PIVOTAL 
TRIAL 
    * TRIAL WILL ENROLL APPROXIMATELY 100 PATIENTS AT FOUR 
CENTERS IN 
U.S. 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nNDL6Wq8zF 
Further company coverage:  ALTHER.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))